Editas Medicine, Inc.
EDIT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001650664
In the last 90 days, Editas Medicine, Inc. insiders filed 0 open-market purchases and 5 sales; 215 institutions reported holding it in 13F filings for Q2 2026, worth $386.3M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Editas Medicine, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 194
- 0 vs. Q1 2025
- Shares held
- 41.3M
- −2.70M (−6.1%) vs. Q1 2025
- Total value
- $90.9M
- +$39.9M (+78.1%) vs. Q1 2025
- New holders
- 26
- 48 more added
- Sold out
- 26
- 52 more reduced
1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EDIT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 215 | $386.3M |
| Q1 2026 | 208 | $127.5M |
| Q4 2025 | 197 | $102.5M |
| Q3 2025 | 194 | $149.3M |
| Q2 2025 | 194 | $90.9M |
| Q1 2025 | 195 | $51.0M |
| Q4 2024 | 207 | $64.8M |
| Q3 2024 | 230 | $187.7M |
| Q2 2024 | 236 | $263.3M |
| Q1 2024 | 226 | $503.8M |
| Q4 2023 | 226 | $595.7M |
| Q3 2023 | 222 | $481.0M |
| Q2 2023 | 238 | $516.8M |
| Q1 2023 | 236 | $384.0M |
| Q4 2022 | 251 | $479.3M |
| Q3 2022 | 265 | $590.5M |
| Q2 2022 | 258 | $561.5M |
| Q1 2022 | 257 | $862.3M |
| Q4 2021 | 307 | $1.36B |
| Q3 2021 | 321 | $2.17B |
| Q2 2021 | 316 | $2.96B |
| Q1 2021 | 314 | $2.23B |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Editas Medicine, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −31,516−100.0% | Sold out |
| Teza Capital Management LLC | 0 | $0 | 0.00% | −23,872−100.0% | Sold out |
| Farringdon Capital, Ltd. | 0 | $0 | 0.00% | −16,327−100.0% | Sold out |
| Pallas Capital Advisors LLC | 0 | $0 | 0.00% | −16,275−100.0% | Sold out |
| Picton Mahoney Asset Management | 0 | $0 | 0.00% | −14,906−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −14,105−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −11,527−100.0% | Sold out |
| TownSquare Capital, LLC | 0 | $0 | 0.00% | −10,559−100.0% | Sold out |
| Pathstone Holdings, LLC | 0 | $0 | 0.00% | −10,530−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −10,275−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −6,005−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −1,582−100.0% | Sold out |
| Evelyn Partners Investment Management LLP | 0 | $0 | 0.00% | −1,200−100.0% | Sold out |
| South State Corp. | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Orion Capital Management LLC | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −178−100.0% | Sold out |
| GHP Investment Advisors, Inc. | 0 | $0 | 0.00% | −164−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −106−100.0% | Sold out |
| Boston Private Wealth LLC | 0 | $0 | 0.00% | −95−100.0% | Sold out |
| Ogorek Anthony Joseph | 0 | $0 | 0.00% | −170−100.0% | Sold out |
| Sandy Spring Bank | – | – | – | – | Not filed |